Global Medical Device Markets Forecast Growth to $28 B by 2033

The global coronary artery bypass graft (CABG) devices market was valued at $17.06 billion in 2025 and is projected to reach $26.58 billion by 2033, expanding at a compound annual growth rate of 5.7%. Growth is driven by the rising prevalence of coronary artery disease and a shift toward off‑pump CABG procedures. Major manufacturers include Medtronic, Boston Scientific, Abbott, Terumo, Cook, and Edwards Lifesciences, which are pursuing product launches, strategic collaborations, and R&D investments.

The worldwide dural repair market was estimated at $1.18 billion in 2025 and is expected to grow to $1.90 billion by 2033, at a CAGR of 6.2%. Demand is fueled by increasing neurological disorders and the expanding use of advanced neurosurgical techniques. Leading players such as Medtronic, Integra LifeSciences, B. Braun Melsungen, and Johnson & Johnson (Codman Neuro) are focusing on new sealants, patches, and dural substitutes, alongside partnerships and research initiatives.